Xia Meng
Corporate Officer/Principal en CELLULAR BIOMEDICINE GROUP, INC. .
Perfil
Xia Meng is currently the Head-Early Diagnosis & Intervention at AbelZeta Pharma, Inc. Prior to this, Dr. Meng held positions as the Head-Institute Merieux Laboratory at Fudan University Shanghai Cancer Center, and as the General Manager at both Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
and Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
Dr. Meng completed an undergraduate degree at Wuhan University and a doctorate degree at Université Pierre et Marie Curie.
Cargos activos de Xia Meng
Empresas | Cargo | Inicio |
---|---|---|
CELLULAR BIOMEDICINE GROUP, INC. | Corporate Officer/Principal | 06/02/2018 |
Antiguos cargos conocidos de Xia Meng.
Empresas | Cargo | Fin |
---|---|---|
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. | Corporate Officer/Principal | - |
Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Corporate Officer/Principal | - |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Corporate Officer/Principal | - |
Formación de Xia Meng.
Wuhan University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Université Pierre et Marie Curie | Consumer Services |
Fudan University Shanghai Cancer Center
Fudan University Shanghai Cancer Center Pharmaceuticals: OtherHealth Technology Fudan University Shanghai Cancer Center is a cancer center that operates in Shanghai, CN. The center was founded in 1931. | Health Technology |
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd.
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. engages in theresearch and development, and manufacture of immunotherapies for the treatment of oncology and infectious diseases. Its business scope includes biopharmaceutical technology development, technology transfer, and related technical advisory services. The company was founded on July 26, 2010 and is headquartered in Tianjin, China. | Commercial Services |
AbelZeta Pharma, Inc.
AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd. |
- Bolsa de valores
- Insiders
- Xia Meng